Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/10/26 20:00 | 7/8/26 | APGE | Health | BioPrd | Biological Products, (No Diag | Henderson Michael Thomas | CA | DO | CEO | 12 | S | -28,691 | 92.55 | 0 | -310 | 1,293 | D | |||||||||||||||
7/2/26 20:13 | 7/1/26 | APGE | Health | BioPrd | Biological Products, (No Diag | Dambkowski Carl | MA | O | Chief Me | 18 | S.d | -10,464 | 79.67 | 0 | -131 | 285 | D | |||||||||||||||
5/4/26 20:00 | 5/1/26 | APGE | Health | BioPrd | Biological Products, (No Diag | Henderson Jane | MA | O | CFO | 12 | S.dm | -2,093 | 76.10 | 0 | -28 | 200 | D | |||||||||||||||
1/22/26 20:07 | 1/22/26 | APGE | Health | BioPrd | Biological Products, (No Diag | Fairmount Funds Management LLC | PA | D | 1 | S.d | -133,525 | 76.30 | 0 | -1,750 | 401 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |